BRPI0821004A2 - Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste - Google Patents
Composto derivado de aminopirazol, composição farmacêutica que o contem e uso desteInfo
- Publication number
- BRPI0821004A2 BRPI0821004A2 BRPI0821004-7A BRPI0821004A BRPI0821004A2 BR PI0821004 A2 BRPI0821004 A2 BR PI0821004A2 BR PI0821004 A BRPI0821004 A BR PI0821004A BR PI0821004 A2 BRPI0821004 A2 BR PI0821004A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- composition containing
- derivative compound
- aminopyrazole derivative
- aminopyrazole
- Prior art date
Links
- -1 Aminopyrazole derivative compound Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007055111 | 2007-12-14 | ||
IB2008053648 | 2008-09-10 | ||
PCT/IB2008/055251 WO2009077954A1 (en) | 2007-12-14 | 2008-12-12 | Aminopyrazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0821004A2 true BRPI0821004A2 (pt) | 2015-06-16 |
BRPI0821004A8 BRPI0821004A8 (pt) | 2017-12-26 |
Family
ID=40456559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0821004A BRPI0821004A8 (pt) | 2007-12-14 | 2008-12-12 | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste |
Country Status (25)
Country | Link |
---|---|
US (1) | US8288419B2 (pt) |
EP (1) | EP2242743B1 (pt) |
JP (1) | JP5435744B2 (pt) |
KR (1) | KR101622413B1 (pt) |
CN (1) | CN101903353B (pt) |
AR (1) | AR069650A1 (pt) |
BR (1) | BRPI0821004A8 (pt) |
CA (1) | CA2706836C (pt) |
CY (1) | CY1114793T1 (pt) |
DK (1) | DK2242743T3 (pt) |
ES (1) | ES2432059T3 (pt) |
HK (1) | HK1148286A1 (pt) |
HR (1) | HRP20131105T1 (pt) |
IL (1) | IL206296A (pt) |
MA (1) | MA31988B1 (pt) |
MX (1) | MX2010005827A (pt) |
MY (1) | MY153921A (pt) |
NZ (1) | NZ586776A (pt) |
PL (1) | PL2242743T3 (pt) |
PT (1) | PT2242743E (pt) |
RU (1) | RU2489426C2 (pt) |
SI (1) | SI2242743T1 (pt) |
TW (1) | TWI430795B (pt) |
WO (1) | WO2009077954A1 (pt) |
ZA (1) | ZA201004939B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ586735A (en) | 2007-12-18 | 2012-06-29 | Actelion Pharmaceuticals Ltd | Aminotriazole derivatives as alx agonists |
TWI490190B (zh) | 2009-05-18 | 2015-07-01 | Actelion Pharmaceuticals Ltd | 橋聯螺〔2.4〕庚烷衍生物 |
WO2010143116A1 (en) | 2009-06-09 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Fluorinated aminotriazole derivatives |
CA2760887A1 (en) * | 2009-06-12 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Oxazole and thiazole derivatives as alx receptor agonists |
EP2556066B1 (en) | 2010-04-07 | 2016-10-19 | F.Hoffmann-La Roche Ag | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
EP2640699B1 (en) | 2010-11-17 | 2015-10-07 | Actelion Pharmaceuticals Ltd. | Bridged spiro[2,4]heptane ester derivatives |
MX2013006418A (es) | 2010-12-07 | 2013-07-15 | Actelion Pharmaceuticals Ltd | Derivados de oxazolil-metileter como agonistas del receptor de alx. |
ES2604135T3 (es) * | 2010-12-07 | 2017-03-03 | Actelion Pharmaceuticals Ltd. | Derivados de aminotriazol hidroxilados como agonistas del receptor ALX |
CA2823877C (en) | 2011-02-18 | 2020-01-07 | Actelion Pharmaceuticals Ltd | Novel pyrazole and imidazole derivatives useful as orexin antagonists |
US20140113824A1 (en) | 2011-05-10 | 2014-04-24 | Bayer Intellectual Property Gmbh | Bicyclic (thio)carbonylamidines |
RU2638552C2 (ru) | 2011-09-27 | 2017-12-14 | Ф. Хоффманн-Ля Рош Аг | Пиразол-4-ил-гетероциклил-карбоксамидные соединения и способы применения |
DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
MA37618B1 (fr) | 2012-05-16 | 2017-08-31 | Actelion Pharmaceuticals Ltd | Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx |
EP2850058B1 (en) | 2012-05-16 | 2016-07-13 | Actelion Pharmaceuticals Ltd. | 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
AR096686A1 (es) | 2013-06-25 | 2016-01-27 | Actelion Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx |
AU2014292064B2 (en) | 2013-07-18 | 2018-07-05 | Idorsia Pharmaceuticals Ltd | Piperazine substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
WO2015079692A1 (ja) | 2013-11-28 | 2015-06-04 | 杏林製薬株式会社 | ウレア誘導体、またはその薬理学的に許容される塩 |
EP3303284B1 (en) | 2015-05-27 | 2020-04-08 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
EP3331884B1 (en) | 2015-05-27 | 2020-06-17 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
PE20210046A1 (es) | 2018-03-05 | 2021-01-08 | Bristol Myers Squibb Co | Agonistas de fenilpirrolidinona del receptor 2 de formil peptido |
CN112313224A (zh) * | 2018-04-06 | 2021-02-02 | 黑带医疗有限责任公司 | Atf6抑制剂和其用途 |
WO2023118434A1 (en) * | 2021-12-22 | 2023-06-29 | Globachem Nv | Pesticidally active amide compounds |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8531019D0 (en) * | 1985-12-17 | 1986-01-29 | Beecham Group Plc | Compounds |
JPS62234018A (ja) | 1986-04-02 | 1987-10-14 | Rooto Seiyaku Kk | 糖尿病併発症治療剤 |
EE04799B1 (et) * | 1999-03-12 | 2007-04-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid |
AU2001290258A1 (en) * | 2000-09-22 | 2002-04-02 | Nihon Nohyaku Co. Ltd. | N-(4-pyrazolyl)amide derivatives, chemicals for agricultural and horticultural use, and usage of the same |
DE60210058T2 (de) * | 2001-03-02 | 2006-11-09 | F. Hoffmann-La Roche Ag | Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten |
AU2003214249A1 (en) | 2002-04-03 | 2003-10-13 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
KR20060130064A (ko) * | 2003-11-07 | 2006-12-18 | 아카디아 파마슈티칼스 인코포레이티드 | 통증 및 염증 치료에 효과적인 화합물을 동정하기 위한도구로서의 리폭신 수용체, fprl1의 용도 |
GB0508472D0 (en) * | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
WO2007055941A2 (en) | 2005-11-03 | 2007-05-18 | Merck & Co., Inc. | Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
GB0606876D0 (en) * | 2006-04-05 | 2006-05-17 | Glaxo Group Ltd | Compounds |
US7939671B2 (en) | 2007-08-21 | 2011-05-10 | Senomyx, Inc. | Compounds that inhibit (block) bitter taste in composition and use thereof |
NZ586735A (en) | 2007-12-18 | 2012-06-29 | Actelion Pharmaceuticals Ltd | Aminotriazole derivatives as alx agonists |
TWI490190B (zh) | 2009-05-18 | 2015-07-01 | Actelion Pharmaceuticals Ltd | 橋聯螺〔2.4〕庚烷衍生物 |
WO2010143116A1 (en) | 2009-06-09 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Fluorinated aminotriazole derivatives |
CA2760887A1 (en) | 2009-06-12 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Oxazole and thiazole derivatives as alx receptor agonists |
-
2008
- 2008-12-11 AR ARP080105380A patent/AR069650A1/es unknown
- 2008-12-12 DK DK08862120.6T patent/DK2242743T3/da active
- 2008-12-12 MY MYPI2010002723A patent/MY153921A/en unknown
- 2008-12-12 BR BRPI0821004A patent/BRPI0821004A8/pt not_active IP Right Cessation
- 2008-12-12 CN CN2008801219752A patent/CN101903353B/zh not_active Expired - Fee Related
- 2008-12-12 MX MX2010005827A patent/MX2010005827A/es active IP Right Grant
- 2008-12-12 KR KR1020107015524A patent/KR101622413B1/ko not_active IP Right Cessation
- 2008-12-12 TW TW097148594A patent/TWI430795B/zh not_active IP Right Cessation
- 2008-12-12 PT PT88621206T patent/PT2242743E/pt unknown
- 2008-12-12 US US12/808,137 patent/US8288419B2/en not_active Expired - Fee Related
- 2008-12-12 RU RU2010128240/04A patent/RU2489426C2/ru not_active IP Right Cessation
- 2008-12-12 EP EP08862120.6A patent/EP2242743B1/en not_active Not-in-force
- 2008-12-12 NZ NZ586776A patent/NZ586776A/en not_active IP Right Cessation
- 2008-12-12 ES ES08862120T patent/ES2432059T3/es active Active
- 2008-12-12 WO PCT/IB2008/055251 patent/WO2009077954A1/en active Application Filing
- 2008-12-12 CA CA2706836A patent/CA2706836C/en not_active Expired - Fee Related
- 2008-12-12 PL PL08862120T patent/PL2242743T3/pl unknown
- 2008-12-12 JP JP2010537589A patent/JP5435744B2/ja not_active Expired - Fee Related
- 2008-12-12 SI SI200831072T patent/SI2242743T1/sl unknown
-
2010
- 2010-06-10 IL IL206296A patent/IL206296A/en not_active IP Right Cessation
- 2010-06-29 MA MA32967A patent/MA31988B1/fr unknown
- 2010-07-13 ZA ZA2010/04939A patent/ZA201004939B/en unknown
-
2011
- 2011-03-11 HK HK11102486.4A patent/HK1148286A1/xx not_active IP Right Cessation
-
2013
- 2013-11-20 CY CY20131101025T patent/CY1114793T1/el unknown
- 2013-11-20 HR HRP20131105AT patent/HRP20131105T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0821004A2 (pt) | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste | |
BRPI0818804A2 (pt) | Composto derivado de pirimidina, composição farmacêutica que o compreende e uso desse composto. | |
BRPI0815190A2 (pt) | Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo | |
BRPI0908208A2 (pt) | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
BRPI0815079A2 (pt) | Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
BRPI0717411A2 (pt) | Uso de inibidores de iap | |
BRPI0915120A2 (pt) | composto derivado de oxima, uso do referido composto e composição farmacêutica | |
BRPI0819299A2 (pt) | Uso de composição, e, composição contendo proteína | |
BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
BRPI0917693A2 (pt) | composto derivado de triazol, composição farmacêutica, e, uso de um derivado de triazol | |
BRPI0921699A2 (pt) | complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo | |
BRPI0907892A2 (pt) | Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2544 DE 08-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |